Executive summary
Procter & Gamble reported fiscal 2027 first-quarter earnings on Thursday, October 22, 2026. The reported results marked an undeniably strong start to the year, beating consensus analysts’ estimates on core earnings per share (EPS) ($2.00 vs. $1.89), revenue ($23.3 billion vs. $22.8 billion), and organic sales growth (+4.0% vs. +3.0%). Growth was balanced, with all 10 product categories and all six regions growing organic sales in the quarter. The Beauty segment registered the strongest results with +5.4% organic sales growth, while Health Care was the trailing segment for the quarter with +2.7% organic sales growth. In the face of continuing high commodity cost headwinds, the $2.00 per share core EPS represented a +1% increase vs. prior year Q1. Market reaction was resoundingly positive, with shares opening at $162.14 (+3.4% above previous day’s close), and trading as high as $166.85 before settling back to close at $165.59 (+5.6%) on a day when the Dow was flat and both the NASDAQ and S&P 500 were down.
In summary, Q1 results were a surprisingly strong start to the year, putting P&G on seemingly solid footing to deliver full fiscal year sales and earnings results within going-in guidance ranges for organic sales growth (+1% to +3%) and core EPS growth (0% to +3%). Management acknowledged the strong start, noting this indicates its category interventions and productivity programs are taking hold and are on point strategically. They also cautioned that risk factors persist, namely commodity cost impacts from sustained high crude oil prices and the potential impacts of inflation, especially in the U.S., on the resilience of the consumer.
What we like
The strong sales growth in the quarter was broad-based across categories and regions. This exceptional balance gives us reason to be optimistic that management’s growth strategy—superior product performance, packaging, and brand communication—is the right choice, that the related plans are being well executed and the investments are beginning to pay off.
Unpacking the strong +4.0% organic sales growth, we find another cause for optimism in volume growth being the primary driver, contributing +2.4% while product mix and pricing contributed +1.1% and +0.4%, respectively. This points to an overall improvement in the foundational health of the business, driven not only by category growth but by improving market share trends. P&G now reports that 29 of its top 50 category/country combinations are holding or growing value share, up from 26 in fiscal 2026. And in North America, P&G’s largest market, it is holding or growing share with 70% of its top U.S. customers – up from less than 10% in the first half of fiscal ’26—helping to drive Q1 volume growth and organic sales growth of +3% in the region.
Finally, we note signs of significant improvement in the Fabric & Home Care and Baby, Feminine & Family Care Segments. Fabric & Home Care delivered +4.8% organic sales growth on +4.3% volume growth in Q1 following 2026 Q4 that saw 0% organic sales growth on +1% volume growth. Baby, Feminine & Family Care delivered +3.0% organic sales growth on +2.3% volume growth in Q1 on the heels of 2026 Q4 that saw organic sales decline -2% with volume declining -1%.
What bears watching
The magnitude and duration of input cost pressures and persistent inflation, especially in the U.S., are variables to monitor. P&G’s fiscal 2027 guidance already includes a cost headwind of approximately $1.4 billion after tax, driven by higher raw material, energy, transportation costs and other premiums, which management attributes primarily to the conflict in the Middle East. This estimate assumes an effective Brent crude oil price of $100 a barrel. The conflict is ongoing, and it is unclear how quickly the benefits of lower oil prices, whenever those might come, would start to flow through the supply chain, relieving the cost pressures for P&G. This puts into focus how important it is for P&G’s productivity programs to continue delivering savings. To illustrate, Q1 core gross margin (% of sales) was down 150 basis points, and core operating margin was down 80 basis points versus last year despite 250 basis points in savings from productivity improvements, as these were more than offset by commodity and freight costs, in addition to demand creation investments.
Notably, P&G continues to invest in its strategy to drive superior product performance, packaging, and brand communication despite the difficult operating environment. This speaks to company leadership managing for the long term, a characteristic attributed to P&G which has prompted many of its investors over the years to keep it as a core portfolio holding.
Another area to watch is potential consumer trade down or reduced consumption that could result from inflation’s continued pressure on households. P&G has a thoughtfully structured brand portfolio in the value, mid, and premium price tiers designed to weather such shifts. The volume-fueled sales growth P&G is seeing now seems to indicate its brand portfolio design is effective, and the consumer is resilient despite elevated inflation.
Bottom line
We characterized P&G’s fiscal 2026 as a “rebuilding year” due to its continued investment in its integrated growth strategy despite slower sales growth, market share challenges, and cost pressures. While still early, the strong start to fiscal 2027 appears to signal that the investments are paying off.